Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.01-113 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

Journal of Thoracic Oncology

English

P3.15-31 Better Clinical Outcomes and Resistance Mechanisms of Crizotinib in ALK-Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.15-27 Patient Characteristics, Treatment Patterns and Survival for Unresectable Stage III NSCLC in Ontario, Canada

Journal of Thoracic Oncology

English

OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P2.16-21 Post-Treatment Survival Difference Between Lobectomy and Stereotactic Ablative Radiotherapy in Stage 1 Non-Small Cell Lung Cancer in England

Journal of Thoracic Oncology

English

Pseudoprogression and Rapid Response to Pembrolizumab in a Patient With Advanced Lung Adenocarcinoma With Loss of Epidermal Growth Factor Receptor Gene Mutation After Tyrosine Kinase Inhibitor Therapy

Journal of Thoracic Oncology

English

MTE17.01 Living With and Beyond Lung Cancer: An Education for Advocates

Journal of Thoracic Oncology

English

GR01.01 Pathology

Journal of Thoracic Oncology

English

P2.11-03 Cardiovascular Risk Prediction in a Community-Based Lung Cancer Screening Programme

Journal of Thoracic Oncology

English

P3.01-83 Use of Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus in Preclinical Models of NSCLC

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.01-113 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

P3.15-31 Better Clinical Outcomes and Resistance Mechanisms of Crizotinib in ALK-Positive Non-Small Cell Lung Cancer

P1.15-27 Patient Characteristics, Treatment Patterns and Survival for Unresectable Stage III NSCLC in Ontario, Canada

OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)

P2.16-21 Post-Treatment Survival Difference Between Lobectomy and Stereotactic Ablative Radiotherapy in Stage 1 Non-Small Cell Lung Cancer in England

Pseudoprogression and Rapid Response to Pembrolizumab in a Patient With Advanced Lung Adenocarcinoma With Loss of Epidermal Growth Factor Receptor Gene Mutation After Tyrosine Kinase Inhibitor Therapy

MTE17.01 Living With and Beyond Lung Cancer: An Education for Advocates

GR01.01 Pathology

P2.11-03 Cardiovascular Risk Prediction in a Community-Based Lung Cancer Screening Programme

P3.01-83 Use of Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus in Preclinical Models of NSCLC